Medical Condition News

RSS

Women who undergo yearly mammography screening have lower rate of palpable tumors

New research findings published in the March issue of the Journal of the American College of Surgeons indicate that some breast cancers continue to be detected as a palpable lump rather than being found through mammographic screening.

16 Mar 2010

MIF exhibits potential as viable therapeutic target for Type 2 diabetes

An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research.

16 Mar 2010

Arthritis drug could be useful for treating patients with type 2 diabetes

Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well.

16 Mar 2010

Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign

While Florida has the second highest cancer burden in the nation, the state has only one National Cancer Institute. Successfully applying for NCI designation must include a commitment for additional funding from the state. The Sylvester Comprehensive Cancer Center is launching “We Tackle Cancer” bringing attention to the critical need for a second NCI.

16 Mar 2010

NKF: Certain ethnic minorities are at higher risk for developing CKD

Certain ethnic minorities, including African Americans and Hispanics, are at a higher risk than the general population for developing potentially life-threatening chronic kidney disease (CKD), which has been linked to higher rates of diabetes and high blood pressure, according to the National Kidney Foundation.

16 Mar 2010

PERSEUS clinical program comparing TAXUS Element Stent to prior-generation stents: 12-month results

Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R) Express(TM) Paclitaxel-Eluting Stent System.

16 Mar 2010

Study offers new possibilities for breast and other cancer therapies

Conventional biological wisdom holds that living cells interact with their environment through an elaborate network of chemical signals. As a result many therapies for the treatment of cancer and other diseases in which cell behavior goes awry focus on drugs that block or disrupt harmful chemical signals.

16 Mar 2010

Drug-eluting stents offer new hope to patients with critical limb ischemia

In the United States, more than 100,000 amputations are performed each year on individuals with critical limb ischemia, the most severe form of peripheral arterial disease (PAD). The number one priority in treating these patients is to re-establish blood flow to avoid limb amputation.

16 Mar 2010

CT scan of heart's epicardial fat provides better prognosis compared to standard diagnostic techniques

Imaging epicardial adipose tissue, or the layer of fat around the heart, can provide extra information compared with standard diagnostic techniques such as coronary artery calcium scoring, according to research by cardiologists at Emory University School of Medicine.

16 Mar 2010

Global Nutrition Transition Conference: Physicians and nutrition scientists to discuss solutions for preventing obesity

Physicians and nutrition scientists from around the world gathered today in Orlando for the opening of the Global Nutrition Transition Conference in order to discuss emerging trends and grass roots solutions to the global obesity epidemic employing balanced nutrition and teaching healthy active lifestyles.

16 Mar 2010

Publix Pharmacies launches first phase of new diabetes management system

Today Publix Pharmacies launched the first phase of a new diabetes management system. The program is a multi-faceted program established to assist customers and associates living with diabetes in managing their medication, compliance, monitoring, education, nutrition and exercise.

16 Mar 2010

EXPLORE-Xa study: Betrixaban reduces CRNM bleeds compared to dose-adjusted warfarin

Portola Pharmaceuticals and Merck today announced the results of EXPLORE-Xa, a Phase 2 exploratory, dose finding study of betrixaban, an investigational oral direct Factor Xa inhibitor. Results showed that a once-daily dose of oral betrixaban, given to patients with non-valvular atrial fibrillation or atrial flutter and at least one risk factor for stroke, reduced the incidence of major and clinically relevant non-major (CRNM) bleeds compared to dose-adjusted warfarin.

16 Mar 2010

Researchers gain new understanding of cilial protein Arl13b in Joubert syndrome

Researchers in Ireland have gained new understanding of the role played by the cilial protein Arl13b in Joubert syndrome (JS), a rare disorder characterized by developmental delay, mental retardation, and low muscle tone, among other symptoms.

16 Mar 2010

Boston Scientific announces results from HORIZONS AMI trial assessing Express bare-metal stent

Boston Scientific Corporation today announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated with the TAXUS® Express2™ Paclitaxel-Eluting Stent System or the Express® bare-metal stent.

16 Mar 2010

Metabolic drugs top the list of prescription drug expenses for elderly Medicare beneficiaries

Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 - about one-fourth of the approximately $82 billion spent for medications for the elderly, according to the latest AHRQ News and Numbers.

16 Mar 2010

UVA Health System offers Gamma Knife eXtend system to treat patients with head and neck cancer

A powerful new tool available at the University of Virginia Health System offers treatment to patients with some of the most challenging cancers of the head and neck.

16 Mar 2010

Vertebroplasty helps patients become better equipped to continue with treatment for multiple myeloma

Treating non-osteoporotic compression fractures in patients with multiple myeloma, a blood cancer, shows that the use of vertebroplasty-a minimally invasive treatment performed by interventional radiologists using imaging guidance that stabilizes collapsed vertebrae with the injection of medical-grade bone cement into the spine-results in a reduction of pain, medication usage and disability, according to researchers in the largest study of its kind at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

16 Mar 2010

Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets primary endpoint

Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that data from a phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia (hoFH) were published in The Lancet. This study met its primary endpoint, resulting in an average LDL-C reduction of greater than 100 mg/dL in this very high-risk patient population.

16 Mar 2010

Gene defects could become targets for new personalised treatments for bowel cancer

Cancer Research UK-funded scientists have discovered that the gene defects that cause some bowel cancers could become the targets for new personalised treatments. Their research is published in Cancer Cell today (Monday).

16 Mar 2010

Tel Aviv University researcher uses magic tricks to treat children with locomotor disabilities

It's often hard to motivate youngsters with physical disabilities. But a new approach from a Tel Aviv University researcher bridges the worlds of behavior and science to help kids with paralysis and motor dysfunction improve their physical skills and inner confidence -- using a trick up her sleeve called "magic."

16 Mar 2010

Medical Condition News

Women who undergo yearly mammography screening have lower rate of palpable tumors

MIF exhibits potential as viable therapeutic target for Type 2 diabetes

Arthritis drug could be useful for treating patients with type 2 diabetes

Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign

NKF: Certain ethnic minorities are at higher risk for developing CKD

PERSEUS clinical program comparing TAXUS Element Stent to prior-generation stents: 12-month results

Study offers new possibilities for breast and other cancer therapies

Drug-eluting stents offer new hope to patients with critical limb ischemia

CT scan of heart's epicardial fat provides better prognosis compared to standard diagnostic techniques

Global Nutrition Transition Conference: Physicians and nutrition scientists to discuss solutions for preventing obesity

Publix Pharmacies launches first phase of new diabetes management system

EXPLORE-Xa study: Betrixaban reduces CRNM bleeds compared to dose-adjusted warfarin

Researchers gain new understanding of cilial protein Arl13b in Joubert syndrome

Boston Scientific announces results from HORIZONS AMI trial assessing Express bare-metal stent

Metabolic drugs top the list of prescription drug expenses for elderly Medicare beneficiaries

UVA Health System offers Gamma Knife eXtend system to treat patients with head and neck cancer

Vertebroplasty helps patients become better equipped to continue with treatment for multiple myeloma

Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets primary endpoint

Gene defects could become targets for new personalised treatments for bowel cancer

Tel Aviv University researcher uses magic tricks to treat children with locomotor disabilities

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News